OOIR: Observatory of International Research

Papers

(The median citation count of Thoracic Cancer is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)

Article	Citations
Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR‐153‐3p/SATB1 signaling pathway	141
	116
Issue Information	102
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	42
Feasibility and safety of secondary video‐assisted thoracoscopic surgery for ipsilateral lung cancer after prior pulmonary resection	33
Pulmonary completion lobectomy after segmentectomy: An integrated analysis of perioperative outcomes	32
Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer	32
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China	31
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report	30
Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation	28
Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging	26
Tracheal polypoid combined small cell lung cancer (C‐SCLC): A case report	24
Issue Information	24
	24
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma	24
Issue Information	24
Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report	23
	23
Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 cases	23
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed	23
Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer re	22
Age‐related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells	22
	22
Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer	21
Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus	21

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	21
A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma	19
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations	19
Issue Information	18
Rapidly developing intrathoracic low‐grade fibromyxoid sarcoma: A case report	18
Lymph node metastasis and its risk factors in T1 lung adenocarcinoma	18
Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis	18
Issue Information	17
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1	17
Prognostic, immunity, stemness, and anticancer drug sensitivity characterization of pyroptosis related genes in non‐small cell lung cancer	17
Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review	17
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	17
Issue Information	17
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis	17
First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report	17
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?	16
Issue Information	16
Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib	15
Identification and validation of the model consisting of DDX49, EGFR, and T‐stage as a possible risk factor for lymph node metastasis in patients with lung cancer	15
Co‐occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case report	15
Safety of anti‐SARS‐CoV‐2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient‐reported	15
Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China	15
Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer	14
Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non‐small cell lung cancer	14
Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung	14
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report	14
Identifying Risk Factors Associated With False‐Negative Results in US‐Guided Percutaneous Transthoracic Needle Lung Biopsy of Subpleural Pulmonary Lesions	14
Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma	14
Life‐threatening extrapleural hematoma in an anticoagulated patient 2 weeks after lobectomy	14
Issue Information	14
	14
Issue Information	14
Correlations between class I glucose transporter expression patterns and clinical outcomes in non‐small cell lung cancer	14
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema	14
Electromagnetic navigational bronchoscopy‐guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy	14
	14
Colorectal Metastasis From Lung Adenocarcinoma With Initial Gastrointestinal Symptoms: A Case Report and Literature Review	14
Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019	14
Pulmonary artery occlusion post immunotherapy for hilar node‐positive lung cancer	13
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	13
Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?	13
Correction to “Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization	13
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids	13
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer	13
Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma	13
Endobronchial brachytherapy combined with surgical procedure for synchronous multiple primary lung cancer: A case report	13
One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient	13
Using a risk model for probability of cancer in pulmonary nodules	13
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report	13
Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer	12

Issue Information	12
Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer	12
Serum miR‐205‐5p level for non–small‐cell lung cancer diagnosis	12
Successful treatment of refractory brain metastases from ALK‐positive lung cancer with lorlatinib	12
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer	12
Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study	12
	12
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An	12
Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma	12
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features	11
Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non‐small cell lung cancer patients	11
Enhanced systemic antitumor efficacy of PD‐1/PD‐L1 blockade with immunological response induced by photodynamic therapy	11
Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib	11
AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines	11
Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma—A rare case report and comprehensive literature review	11
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression	11
	11
Issue Information	11
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring	11
A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer	11
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements	11
Focal ¹⁸F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers	10
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer	10
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study	10
Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD‐L1, IDO, TIM‐3, FOXP3+ and CD8 expressions in patients wit	10
A rare presentation of anaplastic large cell lymphoma as a cavitary pulmonary mass with hypercalcemia	10
An extremely rare case of pulmonary epithelioid hemangioendothelioma	10
Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony‐stimulating factor as support to chemotherapy for lung cancer	10
Thoracic myopericytoma in an older adult, rare but possible: A case report	10
An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy	10
	10
Left sleeve pneumonectomy via uniportal video‐assisted thoracoscopic approach	10
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report	10
Adiponectin‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer	10
Issue Information	10
Observed and relative survival trends of lung cancer: A systematic review of population‐based cancer registration data	10
How to distinguish thoracic and cervical lymph nodes during minimally invasive esophagectomy	10
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401	10
Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy	10
Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report	10
A novel form of precise segmentectomy—Triumphal arch‐like anatomical segmentectomy	10
Endotracheal enucleation and para‐toluenesulfonamide injection for adenoid cystic carcinoma in the upper trachea: A novel therapeutic approach	10
Diagnosis of miliary nodules as lung adenocarcinoma by cryobiopsy: A case report	9
Evaluation of pain levels treated by the distal end of the hook‐wire positioning needle: A randomized controlled study	9
Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumor	9
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer	9
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature	9
Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resection	9
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular	9
Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer	9
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report	9
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	9
	9
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy	9
Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country	9
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report	9
Use of PD‐1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report	9
Issue Information	9
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases	9
Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma	9
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer	9
Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer	9
Two‐stage minimally invasive pulmonary resections with intraoperative localization technique for bilateral multiple primary lung cancers: A case report	9
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting	9
	9
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors	9
Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lu	9
Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland	9
Locally advanced primary mediastinal atypical carcinoid successfully resected after neoadjuvant treatment: A case report	9
	9
Epicardial carvernous hemangioma: The diagnostic challenge of a middle mediastinal mass	9
Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report	9
	8
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	8
The reversal of drug resistance by two‐dimensional titanium carbide Ti₂C (2D Ti2C) in non‐small‐cell lung cancer via the depletion of intracellular antioxidant reserves	8
MiR‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression	8
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	8
Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between differ	8
2024 multidisciplinary consensus on image‐guided lung tumor ablation from the Taiwan Academy of Tumor Ablation	8
Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer	8

Issue Information	8
Issue Information	8
The efficacy of almonertinib and anlotinib combination therapy for advanced non‐small‐cell lung cancer patients who continued to experience cancer progression during third‐generation EGFR‐TKI	8
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size	8
Gene‐level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay	8
	8
Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser‐assisted microdissection: A case report	8
Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion	8
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2	8
Issue Information	8
Surgical outcomes for non‐small cell lung cancer in younger adults: A population‐based study	8
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer	8
Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non–small cell lung cancer by targeting miR‐1182/TFAM axis	8
A prognostic classification based on the International Association for the Study of Lung Cancer histologic grading and immunoscore in KRAS‐mutant invasive non‐mucinous adenocarcinoma	8
Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning	8
Pulmonary mucoepidermoid carcinoma: A clinicopathological study of 45 patients	8
Combined minimally invasive resection of thoracic neurogenic dumbbell tumors: A European case series	8
Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR‐578/EPSTI1 axis	8
Effect of ultrasound‐guided thoracic paravertebral block on perioperative analgesia in elderly patients undergoing video‐assisted thoracic lobectomy in China: An interventional clinical randomized con	8
Relationship between immune‐related adverse events and treatment effectiveness in extensive disease small cell lung cancer	8
Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?	8
	8
Aspergillus ball crawling out of pulmonary bullae	8
Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non‐small cell lung cancer who subsequently underwent immunotherapy	8
Left pulmonary vein anatomical variation in Turner syndrome. Benefits of three‐dimensional visualization for surgical planning	8
Pericancerous lymph node imaging with indocyanine green‐guided near‐infrared fluorescence in radical esophagectomy: Protocol for a single‐center, prospective, randomized controlled clinical trial	8
Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population‐based study in patients with breast cancer	8
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	8
Safety and efficacy of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for patients aged 80 years and older	8
Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema	8
Comparative efficacy of immune checkpoint inhibitors versus chemotherapy alone in diffuse pleural mesothelioma	8
Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC	8
Association of optic nerve sheath lesion and brain or meningeal metastasis caused by lung cancer	8
Circ‐PITX1 promotes non‐small‐cell lung cancer progression through regulating ETS1 expression via miR‐615‐5p	8
Risks of segmentectomy for interstitial pneumonia with diffuse pulmonary ossification	8
Dosimetric comparison of five different radiotherapy treatment planning approaches for locally advanced non‐small cell lung cancer with sequential plan changes	8
Effect of perioperative aspirin continuation on bleeding after pneumonectomy	8
Correction to “Circ‐PDZD8 promotes cell growth and glutamine metabolism in non‐small cell lung cancer by enriching LARP1 via sequestering miR‐330‐5p”	8
Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐	8
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report	8
Detection of Overlooked Rare EGFR Mutations in Non‐small Cell Lung Cancer Using Multigene Testing	7
The Impact of Immune‐Related Adverse Event Severity on Prognosis in Elderly Patients With Nonsmall‐Cell Lung Cancer in First‐Line Immune Checkpoint Inhibitor Treatment	7
Operative outcomes and long‐term survival of patients undergoing colon interposition after esophagectomy for cancer	7
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection	7
	7
Disease control in patients with non‐small cell lung cancer using pemetrexed: Investigating the best treatment strategy	7
Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade	7
Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer	7
Apatinib as maintenance therapy following standard first‐line chemotherapy in extensive disease small cell lung cancer: A phase II single‐arm trial	7
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	7
2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis	7
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer	7
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors	7
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells	7
RETRACTION: Manganese‐12 Acetate Suppresses the Migration, Invasion, and Epithelial–Mesenchymal Transition by Inhibiting Wnt/β‐Catenin and PI3K/AKT Signaling Pathways	7
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	7
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report	7
Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence	7
Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small lung cancer: Post hoc analysis from NE	7
Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor D	7
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)	7
Lung adenocarcinoma with micropapillary and solid patterns: Recurrence rate and trends	7
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1	7
Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers	7
Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma	7
Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy	7
Issue Information	7
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma	7
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study	7
Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer	7
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge	7
Stage IIIA Non‐Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis	7
Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast‐enhanced ultrasound: An updated meta‐analysis	7
Thoracic SMARCA4‐deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report	7
N⁶‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malig	7
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy	7
Effect of Transferrin‐Modified Fe₃O₄ Nanoparticle Targeted Delivery miR‐15a‐5p Combined With Photothermal Therapy on Lung Cancer	7
Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report	7
3D Computed Tomography Reconstruction for Pre‐Operative Diagnosis of Anomalous Venous Drainage of the Right Upper Lobe	7
Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK	7
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers	7
Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradia	7
Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients	7
Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients	7
Marked safety and high diagnostic yield of freehand ultrasound‐guided core‐needle biopsies performed by pulmonologists	7
SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report	7
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	6
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	6
Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small	6
Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice	6
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	6
Immune checkpoint inhibitors for first‐line treatment of advanced non‐small‐cell lung cancer: A systematic review and network meta‐analysis	6
Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma	6
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows	6
Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab	6